Tuesday, 16 June 2026

AutoVRse raises $2.4 M to transform AI-powered training for global pharma and MedTech sectors

Capital raised to fund compliance certifications, LMS/QMS integrations and international expansion

Bengaluru-based AutoVRse, India’s fastest-growing industrial AI transformation platform, has announced a $2.4 million funding round, co-led by Singularity AMC's Large Value Fund III and Early Opportunities Fund, and existing investor Lumikai, India's leading interactive media, digital platforms and games VC.

AutoVRse deploys VR-based training and smart-glasses-enabled field guidance across pharmaceuticals, medical devices and healthcare. The company serves 500,000+ users at more than 50 enterprise customers across North America, Europe, the GCC and India, including five out of the Top-12 pharmaceutical companies globally (by market cap), one of the largest medical device manufacturers in the world, and several other major companies such as Intas, Abbott, Panasonic etc. 

The company's platform, VRseBuilder, works directly with an enterprise's own domain experts — QA leads, cleanroom technicians, clinical applications specialists — to capture their procedural knowledge in a structured, machine-readable format. Every module is authored, reviewed and validated by these subject-matter experts (SME), ensuring that the AI layer is grounded in verified expert knowledge rather than generalised data.

The result is an enterprise-grade "AI Brain": a continuously enriched knowledge layer that converts siloed expertise into structured operational intelligence accessible to every technician, field service engineer and researcher — exactly when they need it, in context, and on the device they are using.

The new capital raised will be used to fund compliance certifications — critical in regulated healthcare environments operating under GMP, QSR and ISO frameworks — and deepen integrations with customer infrastructure including learning management (LMS) and quality management (QMS) systems.

The company also intends to scale its go-to-market in North America, where it is already running deployments with several Fortune 500 companies, and further expand its presence in Europe, the GCC and India.

Published on : 15th June, 2026